Loading…
← CockpitCompetitor Analysis › 300888.SZ Winner Medical Co. Ltd. Class AOpen in the cockpit ↗

Winner Medical Co. Ltd. Class A300888.SZCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Household/Personal Care

Chinese maker of medical dressings, cotton products and consumer health items, also known for its Purcotton brand.

≈ A Chinese medical-supplies and cotton-consumer-products makerMomentum leader 85
Mkt cap
$2.53B
US dollars, full cap
Free float
30%
of shares outstanding
$/day
$15.7M
20-day average traded
Fwd P/E
19.9×
forward earnings
ROIC−WACC
+5.4 pp
WACC 5.8%
Hurdle
-3 pp
Req g minus delivered
Next earnings
161 days
28 Apr 2027
Close · CNYCN¥28.90
1D-1.9%
1W-2.9%
1M-4.9%
3M-1.5%
6M-6.4%
YTD-23.6%
1Y-28.2%
ATR %2.5%
52w lowhigh33.6% off high

What Winner Medical does

Chinese maker of medical dressings, cotton products and consumer health items, also known for its Purcotton brand.

Makes medical dressings and supplies as a contract manufacturer for overseas healthcare buyers, and separately sells its own Purcotton cotton products to consumers in China online and in stores.

In one line: A Chinese medical-supplies and cotton-consumer-products maker.

Products and services

  • Medical dressings/wound care
  • Cotton personal-care products (Purcotton)
  • Baby care products
  • Disposable medical supplies

Customers

  • Hospitals/medical distributors
  • Retail consumers (Purcotton brand)

Where it sits in the supply chain

  • Health Care/Consumer staples
  • Medical supplies & personal care
  • Medical dressings, cotton products…

What could go right

  • Health/hygiene consumer product demand

What could go wrong

  • Medical-supply pricing pressure
  • Consumer brand competition

Moat: narrow (brand, regulatory licence). Medical-device manufacturing licences plus the recognized Purcotton consumer brand.

Headquarters: Shenzhen, China · Employees: 15,855

Named competitors

Winner Medical at a glance

Size Winner Medical (300888.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $2.53B, the 942nd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥28.90 on 18 Nov 2026.

Performance Over six months the shares fell 6.4%, against +9.3% for the median peer and -20.0% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.

Growth Revenue grew 4.1% over the last twelve months (peer median +2.3%); the operating margin is 10.6% (peer median 10.9%).

Valuation It trades at 19.9× forward earnings against a peer median of 23.2× (10th cheapest of 21).

Price implies For today's price to make sense, revenue must grow about -5% a year for seven years (Req g). Recent delivered growth is -3%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 5.4 points above its cost of capital (5.8% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026Peer median 111300888.SZ 95
Six months, rebased to 100: Winner Medical against the median of its 20 peers (local-currency closes).

Winner Medical financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥11.2BCN¥10.9BCN¥8.92BCN¥8.14BCN¥11.3B
Revenue growth—+22%+10%-28%—
Gross profitCN¥5.53BCN¥4.70BCN¥3.74BCN¥3.55BCN¥4.90B
EBITDAn/aCN¥1.87BCN¥1.41BCN¥1.25BCN¥2.27B
Net incomeCN¥777MCN¥768MCN¥695MCN¥580MCN¥1.65B
Free cash flowCN¥905MCN¥1.13BCN¥558MCN¥545MCN¥1.94B
Capital expenditureCN¥761MCN¥648MCN¥901MCN¥753MCN¥1.20B
Total debtCN¥3.52BCN¥3.29BCN¥3.35BCN¥2.49BCN¥2.86B

Quarterly statements and history in the cockpit →

Winner Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%+75%-20%0%+20%GILLETTE1928202367PGHH051900603605269849226993161890492749671044ENRITP7956COTY3009574912300888.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Winner Medical is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%20×40×GILLETTE1928202367PGHH051900603605269849226993161890492749671044EMAMILTDENR7956COTY3009574912300888.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Winner Medical is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%GILLETTE2367PGHH0519006036052698161890492749671044ITP7956COTY3009574912300888.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Winner Medical is the large dot.

Winner Medical competitors and peer comparison

Head to head with its named competitors (300888.SZ vs 002223.SZ vs KMB vs 603301.SS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Winner Medical 300888.SZ$2.53B-6%+4%11%19.9×-5.2%
Jiangsu Yuyue Medical Equipment & Supply 002223.SZ$4.18B-3%-1%13%20.0×4.9%
Kimberly-Clark KMB$65.8B+11%-8%14%15.2×5.1%
Zhende Medical 603301.SS$3.26B-10%+8%7%42.5×22.9%
Hengan Int'l 1044.HK$3.27B-12%+2%11%9.1×-8.2%
ConvaTec CTEC.L$6.78B+37%+2%16%17.7×17.2%
Essity ESSITY-A.ST$19.3B+12%-2%12%15.6×-3.0%

How Winner Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Winner Medical against its 20 peers (data as of 18 Nov 2026)
Measure300888.SZPeer medianRank in peer set
1-month return-4.9%+4.9%6th lowest of 21
6-month return-6.4%+9.3%7th lowest of 21
Distance from 52-week high-33.6%-20.6%5th lowest of 21
Revenue growth (TTM)+4.1%+2.3%10th highest of 21
Operating margin10.6%10.9%11th highest of 21
Forward P/E19.9×23.2×10th cheapest of 21
Growth the price implies (Req g, 7 yrs)-5.2%0.9%4th least demanding of 18
Growth delivered (Del g)-2.6%+5.6%2nd lowest of 18
Hurdle (Req g minus delivered)-2.6 pp-4.0 pp8th most demanding of 18
ROIC minus cost of capital+5.4 pp+5.1 pp9th highest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Winner Medical 300888.SZChina$2.53B-6%+4%11%19.9×-5.2%-2.6%
Gillette India GILLETTE.NSIndia$2.53B-5%+8%28%37.1×14.9%+13.0%
Cosmax 192820.KSSouth Korea$2.51B+53%+25%8%18.8×n/an/a
Giant Biogene 2367.HKHong Kong$2.47B-32%-10%32%8.6×-10.7%+34.9%
Procter & Gamble Hygiene & Health Care PGHH.NSIndia$2.37B-30%-2%24%27.0×21.2%+7.4%
LG H&h 051900.KSSouth Korea$2.81B-14%-3%3%23.1×-4.6%-4.1%
Proya Cosmetics 603605.SSChina$2.87B-13%+2%13%10.9×-5.3%+23.1%
Softcare 2698.HKHong Kong$2.20B+5%+25%25%14.4×9.1%+20.9%
KOSE 4922.TJapan$2.16B+16%+4%5%29.9×n/an/a
Blue Moon 6993.HKHong Kong$2.07B-4%-2%-2%103.3×n/an/a
Kolmar Korea 161890.KSSouth Korea$2.05B+14%+16%10%14.3×-1.6%+15.5%
Pola Orbis 4927.TJapan$2.04B+15%+1%11%30.6×-2.0%-0.7%
Kobayashi Pharmaceutical 4967.TJapan$3.25B+20%+2%6%48.7×18.0%+1.9%
Hengan Int'l 1044.HKHong Kong$3.27B-12%+2%11%9.1×-8.2%-0.1%
Emami EMAMILTD.NSIndia$1.94B-5%+13%20%23.4×21.5%+5.6%
Energizer ENRUnited States$1.94B+71%0%17%9.1×-5.1%-0.5%
Interparfums ITP.PAFrance$3.49B+66%-4%18%26.9×15.6%+19.6%
Pigeon 7956.TJapan$1.76B+26%+8%13%27.9×-2.4%+1.9%
Coty COTYUnited States$3.71B+116%0%5%13.5×9.8%+4.6%
Yunnan Botanee Bio-Technology 300957.SZChina$1.69B-33%+7%9%19.1×2.6%+15.3%
Lion 4912.TJapan$3.85B+44%+6%8%24.3×0.9%+3.5%

Questions

Who are Winner Medical's main competitors?
Named competitors: Yuyue Medical (002223.SZ), Kimberly-Clark (KMB), Zhende Medical (603301.SS), Hengan International (1044.HK), Convatec Group (CTEC.L), Essity (ESSITY-A.ST). The cockpit's measured peer set (industry) also includes Gillette India (GILLETTE.NS), Cosmax (192820.KS), Giant Biogene (2367.HK), Procter & Gamble Hygiene & Health Care (PGHH.NS), LG H&h (051900.KS), Proya Cosmetics (603605.SS).
Is Winner Medical expensive compared with its peers?
On forward p/e it trades at 19.9× against a peer median of 23.2×, 10th cheapest of 21 in its peer set. For today's price to make sense, revenue must grow about -5% a year for seven years (Req g). Recent delivered growth is -3%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Winner Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -6.4% against +9.3% for the median peer; over one year -28.2%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.